Fig. 1.
Growth chart of the patient. Recombinant GH at a physiological dose induced a remarkable change in her growth rate. Breast development occurred spontaneously at the age of 11 yr and 11 mo, and menarche occurred at the age 13 yr and 6 mo, but she had never had regular menstrual cycles; hormone replacement therapy was started due to amenorrhea.